2 months AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat Investor's Business Daily
AbbVie stock jumped Wednesday after the pharma behemoth’s new king in immunology finally outpaced its grandfather drug, Humira.
The post AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat appeared first on Investor's Busines…